Pencil Biosciences
Pencil Biosciences develops a synthetic, modular gene editing platform designed to function without CRISPR technology or DNA breaks. The system is engineered for applications in therapeutics and cell line engineering, specifically targeting oncology and genetic diseases. The platform focuses on providing a flexible and safe alternative to current gene modulation technologies.
Visit websiteLondon, UK
Biotechnology
Gene Editing
Synthetic Biology
Oncology
Funding summary
- Total raised
- €6.5M
- Funding rounds
- 1
Investors in Pencil Biosciences
Investors on record for Pencil Biosciences. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Pencil Biosciences?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors